| WCM Quality Global Growth Fund (Managed Fund) (WCMQ) |
Financials |
$392 |
Actual distribution for year ending 30 June 2025
|
8 Jul 2025 9:40AM |
$9.770 |
$10.660 |
risen by
9.11%
|
|
| Infinity Metals Limited (INF) ORDINARY FULLY PAID |
Materials |
$5 |
San Jose Permit Extension and Drilling Update
|
8 Jul 2025 9:40AM |
$0.016 |
$0.009 |
fallen by
43.75%
|
|
| NEXTDC Limited (NXT) ORDINARY FULLY PAID |
Information Technology |
$10,186 |
Notification of cessation of securities - NXT
|
8 Jul 2025 9:40AM |
$13.870 |
$13.410 |
fallen by
3.32%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$37 |
AR9 Completes $7.5 Million Capital Raising
|
8 Jul 2025 9:39AM |
$0.175 |
$0.076 |
fallen by
56.57%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$91 |
LRT NAV Estimate - 4 July 2025
|
8 Jul 2025 9:39AM |
$1.375 |
$2.200 |
risen by
60%
|
|
| ClearVue Technologies Limited (CPV) ORDINARY FULLY PAID |
Industrials |
$31 |
ClearVue Announces Board and Executive Updates
|
8 Jul 2025 9:38AM |
$0.130 |
$0.088 |
fallen by
32.31%
|
|
CPV - Price-sensitive ASX Announcement
Full Release
Key Points
- ClearVue Technologies Limited announces new Board and executive updates.
- Mr. Martin Deil appointed as Chief Executive Officer and Managing Director.
- Mr. Victor Rosenberg to transition from interim CEO to Non-Executive Director.
- Board and leadership changes align with company’s global expansion strategy.
- Mr. Deil has extensive international experience in building technologies and energy.
- Focus remains on growth in North America, Europe, and Australia.
- The Board thanks Mr. Rosenberg for his contribution as interim CEO.
- Executive changes are effective as of 7 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nufarm Limited (NUF) ORDINARY FULLY PAID |
Materials |
$1,003 |
Application for quotation of securities - NUF
|
8 Jul 2025 9:36AM |
$2.460 |
$2.610 |
risen by
6.10%
|
|
| Kaiser Reef Limited (KAU) ORDINARY FULLY PAID |
Materials |
$130 |
Kaiser Production Update - June Quarter
|
8 Jul 2025 9:36AM |
$0.180 |
$0.215 |
risen by
19.44%
|
|
KAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Kaiser Reef Limited released a production update for the June Quarter.
- Operations focused on the A1 Gold Mine and Maldon Gold Project in Victoria.
- Steady increase in ore production and processed tonnage reported.
- Gold output remained consistent with company expectations.
- Operational improvements and cost management strategies were implemented.
- Safety performance remained a priority with no significant incidents reported.
- Exploration activities continued with promising results supporting resource growth.
- Company remains committed to operational efficiency and sustainability in gold production.
- Ongoing strategies to enhance resource base and future production outlined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asset Management Limited (PTM) ORDINARY FULLY PAID |
Financials |
$1,556 |
Variation to CEO's Remuneration
|
8 Jul 2025 9:35AM |
$0.500 |
$0.695 |
risen by
39%
|
|
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$552 |
Application for quotation of securities - MOT
|
8 Jul 2025 9:35AM |
$2.040 |
$1.655 |
fallen by
18.87%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$37 |
Application for quotation of securities - AR9
|
8 Jul 2025 9:35AM |
$0.175 |
$0.076 |
fallen by
56.57%
|
|
| Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,365 |
Application for quotation of securities - MXT
|
8 Jul 2025 9:35AM |
$2.040 |
$1.930 |
fallen by
5.39%
|
|
| Amaero Ltd (3DA) CHESS DEPOSITARY INTERESTS 40:1 |
Industrials |
$291 |
Velo3D Qualification Condition Satisfied for C103 and Ti64
|
8 Jul 2025 9:34AM |
$0.410 |
$0.305 |
fallen by
25.61%
|
|
3DA - Price-sensitive ASX Announcement
Full Release
Key Points
- Amaero has satisfied the Velo3D Qualification Condition for C103 and Ti64 materials.
- C103 is a niobium alloy; Ti64 is titanium alloy (6Al-4V).
- Qualification expands Amaero’s advanced additive manufacturing capabilities.
- The qualification validates quality, consistency, and material integrity of printed parts.
- Milestone supports growth strategy in aerospace, defense, and space markets.
- Amaero aims to capitalize on demand for high-performance, additively manufactured components.
- Achievement aligns with company focus on innovation and quality assurance.
- Expected to enhance partnerships with industry clients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$6,088 |
Change in substantial holder notice for SPR
|
8 Jul 2025 9:34AM |
$2.370 |
$3.210 |
risen by
35.44%
|
|
| Spartan Resources Limited (SPR) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holder notice from RMS
|
8 Jul 2025 9:34AM |
$1.895 |
$2.130 |
risen by
12.40%
|
|
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
- |
Response to ASX Price Query
|
8 Jul 2025 9:34AM |
$0.205 |
$0.130 |
fallen by
36.59%
|
|
DY6 - Price-sensitive ASX Announcement
Full Release
Key Points
- DY6 Metals Ltd received a price and volume query from the ASX regarding recent trading movements.
- The company confirmed it is not aware of any information not previously announced that could explain the trading activity.
- DY6 Metals stated it is in compliance with the ASX Listing Rules, including continuous disclosure obligations.
- Recent announcements related to DY6's activities in Malawi and project developments have already been disclosed to the market.
- DY6 Metals provided direct written responses to each ASX query, asserting there is no additional undisclosed material information.
- The company restated its commitment to keeping the market fully informed of all relevant information.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Rare Earths Limited (AR3) ORDINARY FULLY PAID |
Materials |
$28 |
Notification of cessation of securities - AR3
|
8 Jul 2025 9:34AM |
$0.054 |
$0.110 |
risen by
103.70%
|
|
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
- |
Proposed issue of securities - DY6
|
8 Jul 2025 9:33AM |
$0.205 |
$0.130 |
fallen by
36.59%
|
|
| DY6 Metals Ltd (DY6) ORDINARY FULLY PAID |
Materials |
- |
Significant expansion to Central Rutile Project
|
8 Jul 2025 9:33AM |
$0.205 |
$0.130 |
fallen by
36.59%
|
|
DY6 - Price-sensitive ASX Announcement
Full Release
Key Points
- DY6 Metals Ltd has expanded the Central Rutile Project by acquiring new mineral sands tenements in Malawi.
- The new tenements are strategically located near existing licenses and are expected to enhance the scale and value of the project.
- The Central Rutile Project is situated in a favorable geological setting with potential for high-grade heavy mineral sands.
- This expansion is part of DY6 Metals’ broader strategy to increase its presence in critical minerals in southern Africa.
- The company will commence further exploration and evaluation of the newly acquired areas.
- DY6 Metals is committed to stakeholder engagement and regulatory compliance as part of its project development.
- The expansion is anticipated to strengthen the company’s position in the mineral sands sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,730 |
Top 20 Securityholders and Distribution Schedule
|
8 Jul 2025 9:32AM |
$4.100 |
$4.550 |
risen by
10.98%
|
|
| Iondrive Limited (ION) ORDINARY FULLY PAID |
Materials |
$43 |
Notification regarding unquoted securities - ION
|
8 Jul 2025 9:31AM |
$0.046 |
$0.033 |
fallen by
28.26%
|
|
| Platinum Asset Management Limited (PTM) ORDINARY FULLY PAID |
Financials |
$1,556 |
PTM Investor Briefing and Presentation Slides
|
8 Jul 2025 9:31AM |
$0.500 |
$0.695 |
risen by
39%
|
|
PTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Overview of Platinum Asset Management Limited's recent financial performance.
- Discussion of investment performance and portfolio positioning.
- Insights into global market conditions impacting the business.
- Strategic priorities for future growth and shareholder value.
- Update on client engagement and retention initiatives.
- Details of cost management and operational efficiency measures.
- Explanation of risk management practices and compliance.
- Information on recent fund developments and product updates.
- Outlook for the investment landscape and business strategy.
- Commitment to ongoing communication with investors and stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Platinum Asset Management Limited (PTM) ORDINARY FULLY PAID |
Financials |
$1,556 |
PTM Enters into Binding Merger Terms with L1 Capital
|
8 Jul 2025 9:30AM |
$0.500 |
$0.695 |
risen by
39%
|
|
PTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Platinum Asset Management Limited (PTM) has entered into a binding Scheme Implementation Deed with L1 Capital.
- The merger will be implemented by way of a scheme of arrangement under Australian law.
- Under the terms, L1 Capital will acquire 100% of PTM shares for a total cash consideration of $1.98 per share.
- The transaction values PTM's equity at approximately $495 million.
- The PTM Board has unanimously recommended shareholders vote in favour of the merger in the absence of a superior proposal and subject to the Independent Expert concluding it is in the best interests of shareholders.
- Major PTM shareholders, including substantial holders and certain directors, have agreed to vote in favour of the merger.
- The merger is subject to customary conditions, including regulatory and court approvals, and approval by PTM shareholders.
- The merger will result in the combination of two leading Australian fund managers with complementary capabilities.
- The merger is expected to create an entity with enhanced scale, diversified investment strategies, and improved market position.
- A Scheme Booklet containing information about the merger will be sent to PTM shareholders, and a shareholder meeting will be held to vote on the proposal.
- The PTM Board has also considered and rejected other proposals as inferior to the L1 Capital offer.
- There is a break fee payable by PTM to L1 Capital in certain circumstances, as outlined in the Deed.
- Key dates and next steps include regulatory submissions, dispatch of Scheme Booklet, and expected implementation in Q3 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,730 |
Settlement of IPO and Satisfaction of Conditions
|
8 Jul 2025 9:27AM |
$4.100 |
$4.550 |
risen by
10.98%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$4 |
EU-GMP Cannabinoid API Supplied for Epilepsy in Slovenia
|
8 Jul 2025 9:26AM |
$0.080 |
$0.036 |
fallen by
55%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Argent Biopharma Limited has supplied a EU-GMP cannabinoid API for epilepsy treatment in Slovenia.
- The cannabinoid API meets strict European Good Manufacturing Practice (EU-GMP) standards.
- Collaboration with local Slovenian healthcare authorities was crucial for product approval.
- This achievement highlights Argent Biopharma’s commitment to regulatory compliance and product quality.
- The introduction of EU-GMP cannabinoid APIs is expected to improve patient access to novel therapies for epilepsy.
- This milestone strengthens Argent Biopharma’s position in the European pharmaceutical and cannabinoid sectors.
- The regulatory approval process in Slovenia is detailed, reflecting stringent quality and safety requirements.
- The announcement underscores the strategic significance of expanding EU-GMP supply chains in Europe.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
